{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-081438","form_type":"8-K","ticker":"TNON","cik":"0001560293","company_name":"Tenon Medical, Inc.","filed_at":"2026-07-24T20:45:38+00:00","discovered_at":"2026-07-24T20:46:00.371586+00:00","generated_at":"2026-07-24T20:46:05.178332+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Tenon Medical shareholders approve reverse stock split and debt financing issuance","bullets":["All seven director nominees elected, including Richard Ferrari, Steven Foster, and others.","Reverse stock split approved at ratio from 1:2 to 1:35; board to set final ratio.","Issuance of shares for convertible notes (debt financing) approved; may exceed 19.99% of outstanding.","Future financings proposal approved for any 20% issuance priced below minimum price.","Ratification of Haskell & White LLP as auditor and adjournment proposal also approved."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-081438","json":"https://secwatch.observer/filing/0001213900-26-081438.json","markdown":"https://secwatch.observer/filing/0001213900-26-081438.md","text":"https://secwatch.observer/filing/0001213900-26-081438.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1560293/000121390026081438/0001213900-26-081438-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1560293/000121390026081438/ea0299237-8k_tenon.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-24T20:46:05.178332+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}